Acquired thrombopathia related to montelukast therapy

Thrombosis and Haemostasis

Volumn 91, Issue 6, 2004, Pages 1247-1248

  Duchemin, Jérôme ^a   Lion, François ^b   Arnaud, Bertrand ^b   Nicot, Marie Cécile ^b   Blouch, Marie Thérèse ^b   Abgrall, Jean François ^b  

^a SERVICE DE RHUMATOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; MONTELUKAST; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ADULT; ANAMNESIS; ARTICLE; ASTHMA; BLOOD ANALYSIS; CASE REPORT; CELL ADHESION; CLINICAL FEATURE; CONCENTRATION RESPONSE; DRUG WITHDRAWAL; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MODULATION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE ANOMALY;

EID: 3042622143     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614262     Document Type: Article

References (9)

1. Jones TR, Labelle M, Belley M, et al. Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist. Can J Physiol Pharmacol 1995; 73: 191-201.
2. Reiss TF, Chervinsky P, Dockhorn RJ, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma. Arch Intern Med 1998; 158: 1213-20.
3. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197-206.
4. Ducharme FM. Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence. Br J Med 2002; 324: 1-7.
5. Mehta P, Mehta J, Lawson D, et al. Leukotrienes potentiate the effects of epinephrine and thrombin on human platelet aggregation. Thromb Res 1986; 41: 731-8.
6. Sarau HM, Ames RS, Chambers J, et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol 1999; 56: 657-63.
7. Pace-Asciak CR, Klein J, Spielberg SP. Metabolism of leukotriene A4 into C4 by human platelets. Biochim Biophys Acta 1986; 877: 68-74.
8. Fiore S, Serhan CN. Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J Exp Med 1990; 172: 1451.
9. Chabannes B, Moliere P, Mehri-Soussi F, et al. Platelets may inhibit leucotriene biosynthesis by human neutrophils at the integrin level. Br J Haematol 2003; 121: 341-8.